Molina Healthcare’s (MOH) “Neutral” Rating Reiterated at Robert W. Baird

Robert W. Baird restated their neutral rating on shares of Molina Healthcare (NYSE:MOH) in a research report released on Tuesday morning, Marketbeat Ratings reports. The brokerage currently has a $375.00 target price on the stock, up from their prior target price of $331.00.

A number of other brokerages also recently weighed in on MOH. Guggenheim started coverage on shares of Molina Healthcare in a research note on Wednesday, April 9th. They issued a “neutral” rating for the company. StockNews.com raised Molina Healthcare from a “hold” rating to a “buy” rating in a report on Friday, April 11th. UBS Group decreased their price objective on Molina Healthcare from $374.00 to $325.00 and set a “neutral” rating on the stock in a research report on Friday, February 7th. JPMorgan Chase & Co. restated a “neutral” rating and set a $350.00 target price (down previously from $378.00) on shares of Molina Healthcare in a research report on Tuesday, December 17th. Finally, Barclays decreased their price target on Molina Healthcare from $372.00 to $339.00 and set an “equal weight” rating on the stock in a report on Friday, February 7th. Nine research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $359.42.

Molina Healthcare Stock Down 3.0 %

Shares of MOH opened at $322.57 on Tuesday. The company has a market capitalization of $17.64 billion, a P/E ratio of 15.79, a PEG ratio of 1.06 and a beta of 0.70. Molina Healthcare has a one year low of $262.32 and a one year high of $370.99. The business’s 50 day simple moving average is $313.00 and its 200-day simple moving average is $308.38. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.62 and a quick ratio of 1.62.

Molina Healthcare (NYSE:MOH) last announced its earnings results on Wednesday, February 5th. The company reported $5.05 EPS for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. As a group, sell-side analysts predict that Molina Healthcare will post 24.4 EPS for the current fiscal year.

Insider Buying and Selling

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $301.33, for a total value of $301,330.00. Following the completion of the sale, the director now directly owns 17,375 shares in the company, valued at $5,235,608.75. This represents a 5.44 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.26% of the stock is currently owned by company insiders.

Institutional Trading of Molina Healthcare

A number of large investors have recently bought and sold shares of the business. Wellington Management Group LLP boosted its holdings in shares of Molina Healthcare by 7.4% in the fourth quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company’s stock valued at $766,111,000 after buying an additional 181,073 shares during the period. FMR LLC boosted its stake in Molina Healthcare by 31.1% in the 4th quarter. FMR LLC now owns 1,801,113 shares of the company’s stock worth $524,214,000 after purchasing an additional 427,276 shares during the period. Geode Capital Management LLC increased its holdings in Molina Healthcare by 2.5% during the 4th quarter. Geode Capital Management LLC now owns 1,436,909 shares of the company’s stock worth $417,144,000 after purchasing an additional 34,992 shares in the last quarter. Invesco Ltd. raised its stake in shares of Molina Healthcare by 28.5% in the 4th quarter. Invesco Ltd. now owns 1,327,021 shares of the company’s stock valued at $386,229,000 after purchasing an additional 294,180 shares during the period. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of Molina Healthcare by 15.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 688,245 shares of the company’s stock valued at $200,307,000 after purchasing an additional 91,229 shares in the last quarter. 98.50% of the stock is owned by institutional investors.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.